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Urinary incontinence affects 17e45% of womenworldwide and stress urinary incontinence is responsible
for 48% of all cases. Detailed history, physical examination and investigations are crucial to identify the
diagnosis underlying the incontinence symptoms to select effective therapy. Although mid-urethral sling
procedures are considered to be ‘gold standard’ treatment of SUI, conservative treatment with pelvic
ﬂoor muscle training and lifestyle modiﬁcation is still the ﬁrst line of management. This article discusses
the diagnosis and conservative management of female SUI.
Copyright  2013, The Asia-Paciﬁc Association for Gynecologic Endoscopy and Minimally Invasive
Therapy. Published by Elsevier Taiwan LLC. All rights reserved.Introduction
The International Continence Society (ICS) deﬁnes stress urinary
incontinence (SUI) as a complaint of involuntary loss of urine on
effort or physical exertion (e.g., sporting activities), or on sneezing
or coughing.1 Urinary incontinence affects 17e45% of women
worldwide and SUI is responsible for 48% of all cases.2 The problem
can occur at any age, but the prevalence and extent of urinary in-
continence rise in women with increasing age. In Taiwan, epide-
miological studies conducted have shown an overall prevalence of
4.3%, but it is 25% in the 50e65 years age group.3 SUI is a social
stigma and it has been shown to restrict social activities of women
suffering from this problem. Only 27% of womenwith SUI seek help,
as they perceive this problem as an occurrence of the natural aging
process.3 SUI is caused by weakening of the pelvic ﬂoor muscles
which support the urethra and bladder (urethral hypermobility)
and/or weakness of the urethral sphincter [intrinsic sphincter
deﬁciency (ISD)]. Risk factors for the development of SUI are
advancing age, obesity, vaginal delivery, vaginal or pelvic surgery,
chronic cough and chronic constipation.4,5
SUI is diagnosed from clinical assessment and urodynamic
studies (UDS). The mid-urethral sling procedure is considered to be
the “gold standard” treatment of SUI, because it is a minimallyDepartment of Obstetrics and
Medical Center, 5, Fu-Hsin
ia-PaciﬁcAssociationforGynecologicEinvasive procedure and it offers high cure rates in a single session
that lasts no more than 30 minutes. Furthermore, it can be per-
formed as an outpatient procedure.6 However, the ﬁrst line man-
agement of SUI is still conservative treatment with pelvic ﬂoor
muscle training (PFMT) and lifestyle modiﬁcations.
Furthermore, surgery of any type is not suitable for all patients.
In particular, women with signiﬁcant comorbidities may not be
good surgical candidates. Moreover, some otherwise healthy SUI
patients may ﬁnd unacceptable the associated risks, pain, and re-
covery time, with no exertional activities (e.g. lifting more than 5 to
10 pounds), and no sexual activity for 6 weeks, and may choose to
forgo surgery, despite continuing SUI symptoms.4
In this review, the diagnosis and conservative management of
SUI will be discussed.
Diagnosis
According to Blaivas, the bladder is an “unreliable witness”; this
is due to the fact that lower urinary tract symptoms are poor pre-
dictors of the underlying diagnosis of urinary incontinence.7
Therefore, history and physical examination are crucial to identify
the diagnosis underlying the incontinence symptoms, to select
effective therapy.8
History
As deﬁned, women with SUI present with a complaint of
involuntary leakage of urine during coughing or sneezing. TheyndoscopyandMinimally InvasiveTherapy.PublishedbyElsevierTaiwanLLC.All rightsreserved.
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tivities like walking, climbing up stairs or routine exercise.
It is important to specify the circumstances, frequency and
severity of leaks of urine inwomenwith SUI when consulting in the
clinic. This can be assessed by various methods, like urinary
symptoms and quality of life questionnaires and a bladder diary. A
3-day bladder diary provides the means for assessing information
on ﬂuid intake (type and amount), voiding frequency and volume,
together with the frequency of leaks.9
Occult SUI may be diagnosed in 25e50% of prolapse patients,10
therefore, complaints of a mass protruding from the vagina
should be queried.
Urinary tract infection (UTI) is a known cause of urinary in-
continence, especially urgency incontinence, and therefore symp-
toms and details regarding treatment of UTI should be sought.
Constipation is one of the causes of incontinence, due to
incomplete bladder emptying; also, chronic straining causes a
weakness of the pelvic ﬂoor muscles, therefore a history of con-
stipation should be elicited.
A detailed medical history should be sought before
commencement of treatment, as it may directly affect bladder
function. Diabetes mellitus and neurologic diseases like Parkinson’s
disease, cerebrovascular accident, multiple sclerosis, spinal cord
injury and congenital defects, may impair sensorimotor function.
Congestive heart failure and chronic respiratory diseases causing
chronic cough, cause abnormal stress to the bladder, by increasing
volume and pressure. Dementia and psychiatric disease lead to
cognitive impairment or failure of voluntary bladder control.
Impaired neuromuscular function, or tissue integrity caused by
vaginal delivery and prior pelvic surgery, are risk factors for stress
incontinence. Details regarding parity, mode of delivery and com-
plications during delivery, such as instrumental use and perineal
trauma should be sought. A history of pelvic surgery, especially
prior surgery for stress incontinence, pelvic organ prolapse and
radical hysterectomy for malignancy, will help in deciding on
further management.
Medication history is important, as it may contribute to urinary
incontinence. Themedicationsare asdescribedwith theirmechanism
of action. Alpha-adrenergic blockers, neuroleptics and benzodiaze-
pines decrease urethral pressure. Bethanechol and cisapride increase
bladder pressure. Diuretics increases bladder pressure and volume of
urine. Anticholinergics, antiparkinsonism agents, b-blockers and dis-
opyramide increase bladder pressure and cause impaired voiding.
These medications affect indirectly; angiotensin-converting-enzyme
inhibitors cause chronic cough, iron and narcoleptics cause con-
stipation and psychotropics cause mental status changes.8
Other risk factors associated with urinary stress incontinence
are obesity (body mass index >30), high impact sports and causes
of an increase in the intra-abdominal pressure, like intra-
abdominal masses11 and chronic cough due to smoking.
Examination
A general examination should include the woman’s BMI,
abdominal and pelvic examination, including assessment of pelvic
ﬂoor muscle tone, and demonstration of urine leakage or the cough
test. Abdominal examination is done to reveal abdominal mass
which may increase pressure on the bladder, causing incontinence.
A neurological examination may be required if the history suggests
possible neuropathology.
The physician must look for objective evidence of involuntary
urine loss, document detrusor function sufﬁcient to empty the
bladder, assess the sphinctermechanism, both intrinsic and extrinsic
to the urethra, and discover any evidence of other causes (e.g., ﬁs-
tulas) of, or contributors (e.g., infection) to, urinary incontinence.Vaginal prolapse should be assessed, as prolapse of the anterior
vagina to or beyond the introitus may result in “paradoxical
continence,” in which poor sphincter function is masked by the
pinching-off of the bladder neck by the prolapse.
The tone and strength of the pelvic ﬂoor muscles can be
assessed by inspection (drawing up of the anus, lifting of the pos-
terior wall of the vagina and narrowing of the vaginal introitus),
digital palpation (e.g., the Oxford score) or more advanced tech-
niques such as perineometry and electromyography.5
The cough test provides the means for documenting SUI. This
clinical test is simple and reproducible. A positive cough test carried
out with an empty bladder, with the patient in the supine position,
tends to indicate an intrinsic urethral sphincter deﬁciency. The
cough test is recommended for documenting SUI prior to surgery.
In cases with a negative cough test, it is recommended to check the
bladder volume and repeat the test, in particular with the patient
standing upright.9
Investigation
Investigations required for conservative management of stress
incontinence are bladder diary, urinalysis, residual urine mea-
surement, uroﬂowmetry test and pad test.
A bladder diary will provide valuable information on the voiding
habit. Patients should be encouraged to complete a minimum of 3
days of the diary, covering variations in their usual activities, such
as bothworking and leisure days.12 The patient records the volumes
voided, as well as the time of each micturition, day and night;
additional information, for example, ﬂuid intake, incontinence
episodes and the use of pads, can be also collected. Such voiding
diaries have been found in a systematic literature review to have
the highest cost-effectiveness of all additional tests that can be used
in primary care alongside clinical history.5
Urinalysis, a mandatory investigation, includes urine dipstick
analysis,microscopy and, culture and sensitivity, which is performed
to rule out UTI. It is also a screening tool for hematuria and glycosuria
as indicators of underlying pathology. If there is persistent micro-
scopic hematuria, further investigation should be carried out with
renal ultrasound and cystoscopy, to rule out other pathology like
calculi or urinary tract malignancy. Positive nitrite and leukocyte
esterase tests for bacteriuria and pyuria, respectively, on dipstick
urinalysis, are 90% speciﬁc for UTI. A urine test for culture and
sensitivity should be performed once dipstick urinalysis is positive.
Glycosuria can be a sign of diabetesmellitus, a disease that can cause
urinary incontinence via several mechanisms, such as neuropathy,
polyuria and recurrentUTI. Proteinuria canbea signof renal disease.5
The measurement of post-void residual volume, by bladder scan
or catheterization, should be performed in women with symptoms
suggestive of voiding dysfunction or recurrent UTI. A bladder scan
should be used in preference to catheterization on the grounds of
acceptability and lower incidence of UTI.12
Uroﬂowmetry, which is a non-invasive procedure, is performed
to measure the ﬂow rate and volume voided per second, to detect
obstructed voiding.
A pad test is only indicated if the patient complains of urinary
incontinence, but it is not clinically demonstrable. A standard 1
hour pad test is performed and if there is an increase in the weight
of the pad by 1 g or more, the test is signiﬁcant.
A urodynamic study is not recommended for conservative
management of stress incontinence; it is mainly indicated before
performing surgery for stress incontinence. However, the purpose
of a urodynamic study, is to reproduce patient symptoms in a
monitored setting; therefore, urodynamic studies are recom-
mended when the history and clinical examination are insufﬁcient
to reach a diagnosis.
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PFMT
PFMT should be the ﬁrst line treatment for stress incontinence,
as it is has no serious adverse effects, however, the training needs
proper instruction and close follow-up to be effective.13
The use of PFMT as a treatment for SUI did not become wide-
spread until after 1948, when Arthur Kegel, a professor of obstetrics
and gynecology in the USA, established its regular practice. In his
paper Progressive resistance exercise in the functional restoration of
the perineal muscles he reported the successful treatment of 64
patients with urinary stress incontinence, hence the term Kegel
exercises, a common misnomer for pelvic ﬂoor exercises as
described by Kegel.11
The rationale for PFMT is based on two concepts, which are
improvement of urethral resistance and pelvic visceral support,
including urethral support, by increasing the strength of the
voluntary PFM and voluntary contraction of the PFM before in-
crease in intra-abdominal pressure.14
An optimal pelvic ﬂoor exercise regime would change the
morphology and position of the muscles to enable subconscious
contraction, a mechanism thought to occur in continent women.15
The pelvic ﬂoor consists of several muscles that include the anal
sphincter, the ischiocavernosus, the bulbospongiosus, the trans-
verse perineal muscle, the striated urogenital sphincter and the
levator ani (puborectalis, pubococcygeus, and iliococcygeus mus-
cles). The PFM are skeletal muscles consisting of 33% fast ﬁbers and
67% slow ﬁbers.16 The normal function of these muscles is to
squeeze around the vaginal, urethral, and anal openings and to lift
inwards in a cranial direction.6
The principles of muscle training are overload, speciﬁcity, main-
tenance and reversibility. Overload can be achieved by maximum
contractions, lengthening of the holding periods, increase in number
of repetitions and reduced rest intervals. Strength training for skel-
etal muscles can be achieved by eight to 12 slow velocity maximal
contractions, three to four series, three to four times a week.
Maximal contractions and the duration of the exercise period are the
most important factors in increasing and maintaining muscle
strength. At least 15e20 weeks of exercise are recommended,
because the effects in the ﬁrst 6e8 weeks are mainly caused by
neural adaptation, and muscle hypertrophy continues over months
and years.6
Speciﬁcity is very important, as many patients contract other
muscles together or instead of PFM. At least 30% of patients cannot
contract these muscles voluntarily, or they may do a valsalva ma-
neuver when asked to contract the PFM. Maintenance of the
training program on a regular basis is important to improve the
length of time and the power of the contraction. Reversibility
means that the length of time and the power of the contraction
decline if the patient follows a reduced exercise program.6
The mechanisms of action of PFMT are by strength training and
counterbalancing. Strength training builds more muscle bulk to the
pelvic ﬂoor, providing support and elevating the levator muscle
plate. It also enhances hypertrophy of the endopelvic fascia, which
increases urethral stability. Counterbalancing is a maneuver per-
formed by consciously contracting the pelvic ﬂoor muscle prior to a
physical stress and then maintaining the contraction during the
stress. This maneuver prevents the urethra and bladder base
descending and enhances continence.11
There is no standardized treatment program, but the National
Institute for Clinical Excellence (NICE) recommends a trial of su-
pervised pelvic ﬂoor exercises, consisting of at least eight con-
tractions three times a day for a minimum of 3 months, as a ﬁrst-
line treatment for urinary incontinence.11It is often reported that PFMT ismore commonly associatedwith
improvement of symptoms, rather than a total cure. However,
short-term cure rates of 35e80%, deﬁned as <2 g of leakage on
different pad tests, have been found after PFMT for SUI.13
The highest cure rate was presented in a study where women
had thorough individual instruction by a trained physiotherapist,
close follow-up once every 2nd week and a total training period of 6
months. High adherence and low dropout were recorded.6
Long-term results depend on compliance and motivation. They
are important factors for the success of PFMT; furthermore,
appropriate training and supervision by a physiotherapist or
specialist nurse is considered essential. Studies have shown that
successful results were maintained after 10 years, in two-thirds of
the patients originally classiﬁed as successful and 33% of the pa-
tients had surgery. However, only 8% had undergone surgery in the
group originally being successful after training, whereas 62% had
undergone surgery in the group initially dissatisﬁedwith training.17
There were no differences in reported frequency or amount of
leakage between women not operated on and women operated on,
and women who had surgery reported signiﬁcantly more severe
leakage and to be more bothered by urinary incontinence during
daily activities, than those not operated on.
As a preventive measure to urinary incontinence, PFMT should
be offered to women in their ﬁrst pregnancy.12
Biofeedback
Biofeedback has been deﬁned as “a group of experimental
procedures where an external sensor is used to give an indication
on bodily processes, usually in the purpose of changing the
measured quality”.13 Biofeedback apparatus is commonly used to
assist with PFMT, where it is combined with PFMT to help women
learn how to contract the PFM to improve training performance.18
They are based on either pressure measurements or surface
EMG.13 Examples of biofeedback are vaginal cones, manometry and
electromyography. Biofeedback is controversial, because studies
have shown that PFMT is effective without biofeedback.13,18 How-
ever, it could be useful inwomenwho cannot actively contract their
PFM, as the information and support generated from biofeedback
assists in motivating them to adhere to therapy.11
Incontinence vaginal pessary
The incontinence vaginal pessary is designed to elevate the
bladder neck and if properly ﬁtted, does not cause outﬂow
obstruction. The vaginal pessary is usually inserted in women who
are unﬁt for surgery, due to advanced age, or have multiple medical
problems. It is also used to treat women with exercise-induced in-
continence. A study by Robert and Mainprize showed that success-
fully ﬁttedwomen had less pelvic surgery and leaked less, but had a
poor success rate for long term use. They concluded that the in-
continencepessarywas successful in a small proportionofwomen.19
Lifestyle modiﬁcation
There are several lifestyle factors that are associated with stress
incontinence. They are obesity, excessive or decreased ﬂuid intake,
smoking, heavy work, or high impact activity and constipation.
Obesity is an independent risk factor for stress incontinence,6
therefore, these women should be referred for a weight loss pro-
gram. Increasing body weight causes increased abdominal weight,
increased intra-abdominal pressure, and increased intravesicular
pressure and urethral mobility, resulting in incontinence. Studies
have shown that a 5e10% weight loss in women with urinary in-
continence resulted inmarked improvement of incontinence, and it
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overweight and obese women to lose weight.20 Obese women are
advised to reduceweight before surgery for stress incontinence and
this may, itself, reduce the severity of stress incontinence, hence
surgery may not be required. A behavioral weight loss intervention
was more effective than an educational control program in
decreasing stress related urinary incontinence through 12 months,
but the beneﬁts at 18 months were more limited. Thus, lifestyle
interventions should be considered the ﬁrst line treatment for
overweight and obese women reporting stress incontinence.21
Type 2 diabetes is associated with a 50e70% increased risk of
incontinence in women, hence, women at high risk for diabetes
who were randomly assigned to an intensive lifestyle intervention
involving weight loss and exercise, had a substantially lower
prevalence of SUI.20
Women with stress incontinence, who consume excessive
amounts of ﬂuid as recorded in the bladder diary, should be advised
to reduce their ﬂuid intake. By contrast, those who severely reduce
intake are prone to UTI and constipation, which would worsen the
incontinence, therefore should be advised regarding adequate
amounts of ﬂuid intake.
Constipation is associated with urinary incontinence. Straining
during defecation may lead to pudendal nerve damage, or weaken
the PFM, hence, women should be advised on adequate ﬂuid intake,
a high ﬁber diet and may need stool softeners or laxatives to alle-
viate symptoms.
Smoking is another independent risk factor for urinary stress in-
continence. A recent study on the relation between maximal intra-
vesicalpeakpressuregeneratedbycough(CIPP) andclinical factors in
stress incontinence, found that current and former smokers has a
similar risk factor. Therefore smoking has a long-lasting effect and
women should be advised to refrain from smoking.22
In conclusion, before conservative management of SUI, a
detailed history, clinical examination and investigations should be
performed to diagnose SUI. Once diagnosis is made, the ﬁrst line
treatment is PFMT and lifestyle modiﬁcations like weight loss,
especially for women who are obese.References
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